1. Home
  2. VERU vs GRWG Comparison

VERU vs GRWG Comparison

Compare VERU & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • GRWG
  • Stock Information
  • Founded
  • VERU 1971
  • GRWG 2008
  • Country
  • VERU United States
  • GRWG United States
  • Employees
  • VERU N/A
  • GRWG N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • GRWG RETAIL: Building Materials
  • Sector
  • VERU Health Care
  • GRWG Consumer Discretionary
  • Exchange
  • VERU Nasdaq
  • GRWG Nasdaq
  • Market Cap
  • VERU 85.5M
  • GRWG 98.0M
  • IPO Year
  • VERU 1990
  • GRWG N/A
  • Fundamental
  • Price
  • VERU $3.42
  • GRWG $1.60
  • Analyst Decision
  • VERU Strong Buy
  • GRWG Strong Buy
  • Analyst Count
  • VERU 3
  • GRWG 1
  • Target Price
  • VERU $33.33
  • GRWG $2.50
  • AVG Volume (30 Days)
  • VERU 120.2K
  • GRWG 561.0K
  • Earning Date
  • VERU 08-12-2025
  • GRWG 11-11-2025
  • Dividend Yield
  • VERU N/A
  • GRWG N/A
  • EPS Growth
  • VERU N/A
  • GRWG N/A
  • EPS
  • VERU N/A
  • GRWG N/A
  • Revenue
  • VERU $16,886,419.00
  • GRWG $164,108,000.00
  • Revenue This Year
  • VERU N/A
  • GRWG N/A
  • Revenue Next Year
  • VERU N/A
  • GRWG N/A
  • P/E Ratio
  • VERU N/A
  • GRWG N/A
  • Revenue Growth
  • VERU 337.24
  • GRWG N/A
  • 52 Week Low
  • VERU $2.64
  • GRWG $0.82
  • 52 Week High
  • VERU $14.20
  • GRWG $2.27
  • Technical
  • Relative Strength Index (RSI)
  • VERU 43.02
  • GRWG 54.64
  • Support Level
  • VERU $3.40
  • GRWG $1.59
  • Resistance Level
  • VERU $3.68
  • GRWG $1.74
  • Average True Range (ATR)
  • VERU 0.22
  • GRWG 0.11
  • MACD
  • VERU 0.08
  • GRWG -0.02
  • Stochastic Oscillator
  • VERU 27.78
  • GRWG 39.39

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.

Share on Social Networks: